PASHUN INT'L (00574) receives resumption guidance.
Bai Xing International (00574) announced that on July 14, 2026, the company received a letter from the Stock Exchange, which stipulated the following guidelines for the resumption of trading in the company's shares: (a) to provide evidence that the company complies with Rule 13.24 of the listing rules; (b) to withdraw or reject any winding-up petition (or winding-up order, if any) against the company, and to revoke the appointment of the liquidator (whether temporary or not); (c) to comply again with Rule 3.10(1) and Rule 3.21 of the listing rules; and (d) to disclose all material information to the market for the assessment of the company's status by shareholders and investors.
PASHUN INT'L (00574) announced that on July 14, 2026, the company received a letter from the Stock Exchange containing guidelines for the resumption of trading of the company's shares, including: (a) confirming the company's compliance with Listing Rule 13.24; (b) withdrawing or rejecting any winding-up petitions (or winding-up orders, if any) against the company, and revoking the appointment of the liquidator (whether temporary or permanent); (c) re-complying with Listing Rule 3.10(1) and 3.21; and (d) disclosing all material information to the market for evaluation by the company's shareholders and investors.
Related Articles
On July 16th, SIPAI HEALTH (00314) spent approximately HK$37,200 to repurchase 26,200 shares.
7ROAD (00797) spent HK$2.057 million to buy back 1.8 million shares on July 16th.
Techtronic Industries (00669) spent HKD 415,340 to repurchase 32,000 shares on July 16th.
On July 16th, SIPAI HEALTH (00314) spent approximately HK$37,200 to repurchase 26,200 shares.
7ROAD (00797) spent HK$2.057 million to buy back 1.8 million shares on July 16th.
Techtronic Industries (00669) spent HKD 415,340 to repurchase 32,000 shares on July 16th.
RECOMMEND
